Phase I and pharimacokinetic trial of a novel inhibitor of NAD biosynthesis in patients with solid tumors.

被引：0
|
作者：
Holen, KD
Bolling, C
Saltz, LB
Graefe, T
Ty, V
Sogo, N
Starkmann, H
Burk, KH
Hollywood, E
Hanauske, AR
机构：
[1] St Georg Hosp, Hamburg, Germany
[2] Univ Wisconsin, Madison, WI USA
[3] MSKCC, New York, NY USA
[4] Fujisawa Pharmaceut Co Ltd, Osaka, Japan
[5] Fujisawa Deutschland GmbH, Munich, Germany
[6] ClinDesci GmbH, Munich, Germany
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6158S / 6158S
页数：1
相关论文
共 50 条
  • [21] Phase I trial of sorafenib, bevacizumab, and temsirolimus in advanced solid tumors.
    Westin, Shannon Neville
    Smart, Melody L.
    Pal, Navdeep
    Urbauer, Diana L.
    Janku, Filip
    Wheler, Jennifer J.
    Piha-Paul, Sarina Anne
    Naing, Aung
    Tsimberidou, Apostolia Maria
    Fu, Siqing
    Falchook, Gerald Steven
    Hong, David S.
    Zinner, Ralph
    Subbiah, Vivek
    Culotta, Kirk Salvatore
    Lu, Karen H.
    Coleman, Robert L.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] A phase I trial of veliparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors.
    Hendrickson, Andrea Elisabeth Wahner
    Menefee, Michael E.
    Hartmann, Lynn C.
    Long, Harry J.
    Northfelt, Donald W.
    Reid, Joel M.
    Boakye-Agyeman, Fleix
    Flatten, Karen S.
    Poirier, Guy G.
    Lensing, Janet
    Erlichman, Charles
    Kaufmann, Scott H.
    Haluska, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Phase I study of pazopanib and ixabepilone in patients with solid tumors.
    Ganesan, Chitra
    Obulareddy, J.
    Bliss, Robin L.
    Dudek, Arkadiusz Z.
    CANCER RESEARCH, 2013, 73 (08)
  • [24] A phase I study of IPI-926, a novel hedgehog pathway inhibitor, in patients (pts) with advanced or metastatic solid tumors.
    Rudin, C. M.
    Jimeno, A.
    Miller, W. H.
    Eigl, B. J.
    Gettinger, S. N.
    Chang, A. L. S.
    Faia, K.
    Sweeney, J.
    Loewen, G.
    Ross, R. W.
    Weiss, G. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] A phase 1 trial of a potent and selective VEGF receptor inhibitor, apatinib, in patients with advanced solid tumors.
    Sharma, Sunil
    Kang, Yoon-Koo
    Weis, John R.
    Gilcrease, Glynn Weldon
    Davidson, Cynthia
    Kingsford, Rachel
    Collett, Joan
    Orgain, Nicole
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Park, Sook Ryun
    Yoo, Hee-Won
    Kim, Sung-Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumors.
    De Bono, Johann Sebastian
    Mina, Lida A.
    Gonzalez, Michael
    Curtin, Nicola J.
    Wang, Evelyn
    Henshaw, Joshua W.
    Chadha, Manpreet
    Sachdev, Jasgit C.
    Matei, Daniela
    Jameson, Gayle S.
    Ong, Michael
    Basu, Bristi
    Wainberg, Zev A.
    Byers, Lauren Averett
    Chugh, Rashmi
    Dorr, Andrew
    Kaye, Stanley B.
    Ramanathan, Ramesh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Phase I study of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors.
    Cescon, David W.
    Hansen, Aaron Richard
    Razak, Albiruni Ryan Abdul
    Stayner, Lee-Anne
    Hilton, John Frederick
    Renouf, Daniel John
    Denny, Trisha
    Fletcher, Graham
    Mak, Tak W.
    Bray, Mark R.
    Bedard, Philippe L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Phase I trial of BAY 73-4506, a kinase inhibitor that targets oncogenic and angiogenic kinases, in patients with advanced solid tumors.
    Frost, A.
    Hedbom, S.
    Steinbild, S.
    Buchert, M.
    Unger, C.
    Christensen, O.
    Voliotis, D.
    Heinig, R.
    Mross, K.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3459S - 3460S
  • [29] A first-in-human phase I trial of AR-12, a PDK-1 inhibitor, in patients with advanced solid tumors.
    Mateo, Joaquin
    De Bono, Johann Sebastian
    Ramanathan, Ramesh K.
    Lustberg, Maryam B.
    Zivi, Andrea
    Basset, Dawn
    Ng, Matthew
    Young, Anna-Mary
    Garrett, Michelle
    Decordova, Shaun
    Raynaud, Florence I.
    Yap, Timothy Anthony
    Zukiwski, Alexander A.
    Proniuk, Stefan
    Shapiro, Charles L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Phase I trial of sequential paclitaxel and cisplatin in combination with the cyclin dependent kinase inhibitor flavopiridol (flavo) in patients with advanced solid tumors.
    Schwartz, GK
    Kaubisch, A
    Saltz, L
    Ilson, D
    O'Reilly, E
    Barazzuol, J
    Endres, S
    Stoltz, M
    Tong, W
    Kelsen, DP
    Spriggs, D
    CLINICAL CANCER RESEARCH, 1999, 5 : 3754S - 3754S
12345